Pfizer To See No Major M&A Activity In 2024: Ceo Bourla

Pfizer to See No Major M&A Activity in 2024: CEO Bourla

Bloomberg Television

Pfizer's weight loss pill may enter regulatory studies next year, says CEO Albert Bourla

CNBC Television

Pfizer CEO on Sales, M&A, mRNA, Weight Loss Drug

Bloomberg Television

Pfizer CEO: Weight loss pill may enter regulatory studies next year

CNBC Television

Pfizer Buys Cancer-Drug Maker Seagen for $43 Billion

Bloomberg Television

Pfizer CEO: Cancer drugs will be our next big contribution to the world

CNBC Television

Pfizer has no further investment plans in Russia, CEO says

Face the Nation

Pfizer's efforts to regain investor trust

Pfizer CEO doubles down on 2024 guidance, talks Seagen buy

💉 Pfizer CEO on merger with Seagen, cancer treatment breakthroughs 🔬🧑‍🔬 #shorts

Final Trades: Pfizer, Bristol Meyers, Textron and Oracle

CNBC Television

Pfizer to provide 2 billion doses to low and lower-middle-income countries: Pfizer CEO Albert Bourla

TheRightDoctors

Pfizer CEO Dr. Bourla's "Moonshot: Inside Pfizer's Nine-Month Race to Make the Impossible Possible"

Center for Strategic & International Studies

Mistral CEO Arthur Mensch on AI tech race, open- vs. closed-source LLM and AI partnerships

CNBC Television

Pfizer CEO Albert Bourla talks Q3 earnings results with Jim Cramer

CNBC Television

COVID-19 Vaccine | USA Gives Nod To Pfizer-BioNTech’s Vaccine, Pfizer’s CEO Refuses A Shot

Seagen has one of the greatest technologies to battle cancer: Pfizer CEO on acquisition

CNBC Television

Pfizer CEO on prescription drug prices: We have a problem here... this needs to change

Bausch + Lomb CEO on strength in eye care, competitive positioning

CNBC Television